DEF 14A

Company

BioNexus Gene Lab Corp

Filed

February 27, 2025

Period of Report

March 19, 2025

Accession Number

0001477932-25-001335

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →